• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transcatheter aortic valve replacement.经导管主动脉瓣置换术
Mo Med. 2012 Jul-Aug;109(4):301-6.
2
Transcatheter aortic valve implantation: patient selection and procedural considerations.
Future Cardiol. 2011 Jul;7(4):499-509. doi: 10.2217/fca.11.26.
3
Transcatheter aortic valve replacement.经导管主动脉瓣置换术
Dimens Crit Care Nurs. 2012 Nov-Dec;31(6):311-7. doi: 10.1097/DCC.0b013e31826bc60e.
4
Transfemoral transcatheter ACURATE-neo™ aortic valve replacement in a patient with a previous mechanical mitral valve.经股动脉经导管为一名曾接受机械二尖瓣置换术的患者植入ACURATE-neo™主动脉瓣膜。
J Card Surg. 2017 Jun;32(6):358-360. doi: 10.1111/jocs.13153. Epub 2017 May 24.
5
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).经导管与外科主动脉瓣置换术治疗高危主动脉瓣狭窄合并左心室功能不全患者的疗效:主动脉经导管瓣膜置入(PARTNER)试验(A队列)结果
Circ Cardiovasc Interv. 2013 Dec;6(6):604-14. doi: 10.1161/CIRCINTERVENTIONS.113.000650. Epub 2013 Nov 12.
6
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.手术风险增加的重度主动脉瓣狭窄患者经导管或外科主动脉瓣置换术后的健康状况:CoreValve美国关键试验的结果
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.
7
Minimally invasive aortic valve replacement with sutureless valve is the appropriate treatment option for high-risk patients and the "real alternative" to transcatheter aortic valve implantation.采用无缝合瓣膜的微创主动脉瓣置换术是高危患者的合适治疗选择,也是经导管主动脉瓣植入术的“真正替代方案”。
J Thorac Cardiovasc Surg. 2016 Mar;151(3):610-613. doi: 10.1016/j.jtcvs.2015.10.028. Epub 2015 Oct 19.
8
Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.经皮导管主动脉瓣植入术治疗退化的外科生物瓣膜:亚洲首个随访一年的病例系列。
Singapore Med J. 2016 Jul;57(7):401-5. doi: 10.11622/smedj.2016097. Epub 2016 May 19.
9
Transcatheter aortic valve implantation (TAVI): first case in Thailand.经导管主动脉瓣植入术(TAVI):泰国首例病例。
J Med Assoc Thai. 2012 Jan;95(1):124-8.
10
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.经导管主动脉瓣置换术使用自扩张生物瓣治疗手术高危重度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19.

本文引用的文献

1
Outcomes of less invasive J-incision approach to aortic valve surgery.经改良的 J 型切口行主动脉瓣手术的结果。
J Thorac Cardiovasc Surg. 2012 Oct;144(4):852-858.e3. doi: 10.1016/j.jtcvs.2011.12.008. Epub 2012 Jan 12.
2
Mini-sternotomy for aortic valve replacement reduces the length of stay in the cardiac intensive care unit: meta-analysis of randomised controlled trials.主动脉瓣置换术的胸骨下段小切口可缩短心脏重症监护病房的住院时间:随机对照试验的荟萃分析
BMJ Open. 2011 Nov 24;1(2):e000266. doi: 10.1136/bmjopen-2011-000266. Print 2011.
3
Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.瑞舒伐他汀对 C 反应蛋白和主动脉瓣狭窄进展的影响。
Am Heart J. 2011 Jun;161(6):1133-9. doi: 10.1016/j.ahj.2011.03.016.
4
Transcatheter versus surgical aortic-valve replacement in high-risk patients.经导管主动脉瓣置换术与外科主动脉瓣置换术在高危患者中的比较。
N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.
5
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.经导管主动脉瓣植入术治疗不能手术的主动脉瓣狭窄患者。
N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.
6
Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Hancock II 生物瓣置换主动脉瓣:生物瓣耐久性的金标准?
Ann Thorac Surg. 2010 Sep;90(3):775-81. doi: 10.1016/j.athoracsur.2010.05.034.
7
Valvular heart disease: a perspective on the asymptomatic patient with severe valvular aortic stenosis.心脏瓣膜病:重度主动脉瓣狭窄无症状患者的视角
Eur Heart J. 2008 Jul;29(14):1783-90. doi: 10.1093/eurheartj/ehn272. Epub 2008 Jun 23.
8
Aortic valve replacement in octogenarians: risk factors for early and late mortality.八旬老人主动脉瓣置换术:早期和晚期死亡的危险因素
Ann Thorac Surg. 2007 May;83(5):1651-6; discussion 1656-7. doi: 10.1016/j.athoracsur.2006.09.068.
9
Minimally invasive approaches to aortic valve surgery: Brigham experience.主动脉瓣手术的微创方法:布莱根妇女医院的经验。
Semin Thorac Cardiovasc Surg. 2006 Summer;18(2):148-53. doi: 10.1053/j.semtcvs.2006.07.007.
10
Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis.453例非手术治疗的重度主动脉瓣狭窄患者的临床特征及自然病史
Ann Thorac Surg. 2006 Dec;82(6):2111-5. doi: 10.1016/j.athoracsur.2006.07.048.

经导管主动脉瓣置换术

Transcatheter aortic valve replacement.

作者信息

Maniar Hersh S, Zojarias Alan

机构信息

Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, USA.

出版信息

Mo Med. 2012 Jul-Aug;109(4):301-6.

PMID:22953594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6179791/
Abstract

Aortic stenosis is the most common form of valvular heart disease in the Western world and until recently, surgical aortic valve replacement has been the only treatment available for patients with this disease that has been shown to improve both symptoms and survival. Transcatheter aortic valve replacement has emerged as a new therapy for patients with severe aortic stenosis who are poor surgical candidates due to their elevated surgical risk. As longer follow up is obtained and improvements continue to be made in the current available prostheses, transcatheter aortic valve replacement will likely become a treatment alternative for high-risk patients with severe aortic stenosis.

摘要

在西方世界,主动脉瓣狭窄是最常见的心脏瓣膜疾病形式,直到最近,外科主动脉瓣置换术一直是这种疾病患者唯一经证实可改善症状并提高生存率的治疗方法。经导管主动脉瓣置换术已成为一种新的治疗方法,适用于因手术风险高而不适合手术的严重主动脉瓣狭窄患者。随着随访时间延长以及现有假体不断改进,经导管主动脉瓣置换术可能会成为高危严重主动脉瓣狭窄患者的一种治疗选择。